Gujarat Alkalies and Chemicals Limited has informed the Exchange regarding Appointment of M/s Talati & Talati LLP as Internal Auditor of the company w.e.f. July 01, 2025.
GUJALKALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.3 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved audited financial results for Q4 and FY25 (ended 31 March 2025). On a standalone basis, the company swung to a net profit of Rs. 9.72 crore in FY25 from a loss of Rs. 185.88 crore in FY24, while revenue rose modestly to Rs. 4,072.91 crore (vs Rs. 3,806.63 crore). Consolidated results, however, remain in the red with a net loss of Rs. 71.22 crore (vs Rs. 300.48 crore loss), dragged by the 60% GACL-NALCO joint venture which posted a loss of Rs. 134.96 crore and accumulated losses of Rs. 594.68 crore. The board recommended a final dividend of Rs. 15.80 per share (158% on face value), totalling Rs. 116.03 crore. M/s Talati & Talati LLP was appointed as Internal Auditor for one year from 1 July 2025, and M/s Samdani Shah & Kabra as Secretarial Auditor for five years. IAS officer Shri S J Haider was inducted as Additional Director, subject to shareholder approval via postal ballot.
Shareholders get a healthy Rs. 15.80/share dividend and will welcome the standalone turnaround. However, the consolidated loss, the bleeding joint venture, a new financial guarantee obligation of Rs. 32.34 crore backing JV debentures, and a post-balance-sheet technical shutdown at the JV plant are risks that could weigh on sentiment despite the clean auditor's opinion.